New Genetic Cause Of A Fatal Immune Disorder
- Date:
- December 30, 2009
- Source:
- Journal of Clinical Investigation
- Summary:
- Familial hemophagocytic lymphohistiocytosis (FHL) is an inherited, fatal, immune disorder. Disease-causing mutations have been identified in several genes. Now, researchers have added a new gene to this list by determining that two distinct mutations in the gene that generates syntaxin-binding protein 2 cause disease in a subset of patients with FHL.
- Share:
Familial hemophagocytic lymphohistiocytosis (FHL) is an inherited, fatal, immune disorder characterized by uncontrolled activation of immune cells known as lymphocytes and macrophages. Disease-causing mutations have been identified in several genes that generate proteins involved in lymphocyte-mediated cell death, including syntaxin-11.
Now, Geneviève de Saint Basile and colleagues, at INSERM U768, France, have added a new gene to this list by determining that two distinct mutations in the gene that generates syntaxin-binding protein 2 (Munc18-2; also known as STXBP2) cause disease in a subset of patients with FHL; this form of the disease was then termed 'FHL5'.
The research is reported in the Journal of Clinical Investigation.
Mechanistically, the two distinct STXBP2 mutations led to substantially decreased STXBP2 protein in patient lymphoblasts and impaired release of death-inducing molecules from immune cells known as NK cells. Further analysis indicated that the predominant protein to which STXBP2 binds in lymphocytes is syntaxin-11. The authors therefore conclude that STXBP2 binds syntaxin-11, thereby controlling a late step of the secretory pathway that releases death-inducing molecules; in patients with FHL5, the STXBP2 protein deficiency means this process cannot occur efficiently.
Story Source:
Materials provided by Journal of Clinical Investigation. Note: Content may be edited for style and length.
Journal Reference:
- Côte et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. Journal of Clinical Investigation, 2009; DOI: 10.1172/JCI40732
Cite This Page: